MARKET

LGVN

LGVN

Longeveron Inc
NASDAQ
0.6301
+0.0351
+5.90%
Opening 10:53 07/30 EDT
OPEN
0.5950
PREV CLOSE
0.5950
HIGH
0.6400
LOW
0.5861
VOLUME
117.80K
TURNOVER
--
52 WEEK HIGH
1.750
52 WEEK LOW
0.4750
MARKET CAP
19.91M
P/E (TTM)
-0.5398
1D
5D
1M
3M
1Y
5Y
1D
Longeveron Restores Nasdaq Compliance with New Audit Committee
TipRanks · 1d ago
Longeveron regains Nasdaq audit committee compliance after board reshuffle
PUBT · 1d ago
Weekly Report: what happened at LGVN last week (0720-0724)?
Weekly Report · 3d ago
*Deborah D. Ascheim, M.D. Elected to Longeveron Bd of Directors
Dow Jones · 07/23 13:16
Longeveron elects Deborah Ascheim to board of directors
PUBT · 07/23 13:15
DEBORAH D. ASCHEIM, M.D. ELECTED TO LONGEVERON BOARD OF DIRECTORS
Reuters · 07/23 13:15
Press Release: Deborah D. Ascheim, M.D. Elected -2-
Dow Jones · 07/23 13:15
Press Release: Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
Dow Jones · 07/23 13:15
More
About LGVN
Longeveron Inc. is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action, encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. The Company is pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. Lomecel-B development programs have received five distinct FDA designations: for the HLHS program - Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program - Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation.

Webull offers Longeveron Inc stock information, including NASDAQ: LGVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGVN stock methods without spending real money on the virtual paper trading platform.